Conexx was pleased to lead another delegation to the 2016 IATI-Biomed Conference in Tel Aviv, Israel this past May. The 15th annual conference saw over a thousand people from over 40 countries and included over 6,000 senior executives, scientists and engineers from the healthcare/medical fields as well as 4,500 one-on-one meetings.
The Conexx delegation included participants from Tennessee and Georgia and represented the government and private medical instrument sectors. The Conexx Healthcare Connector and Chair, Ralph Jordan, had been working to assist both U.S. companies and States make strategic connections and identify partners in Israel leading up to Biomed.
In addition to the Biomed conference, the Conexx delegation was able to attend some incredible meetings. In Jerusalem, participants traveled to Hadassah Medical Center where they met with professors at Hebrew University as well as doctors with BioJerusalem and Hadasit Bio Holdings, the Hadassah Tech Transfer company. The mission also took participants to the Nazareth Technology Park where they met Reem Younis, Co-Partner of Alpha Omega Engineering and fellow Conexx member as well as Dr. Rami Halabi, Chairman of Tsofen, an organization promoting the integration of Israel’s Arab citizens in the hitech industry.
At the Biomed conference, the Conexx delegation was witness to some exciting business deals. NeuroRx, a clinical stage pharma company that treats central nervous systems disorders, specifically those surrounding suicide, won the IATI-Biomed startup competition as the most innovative life science company. The company was chosen amongst dozens of startups.
In other news, OrbiMed, the international healthcare venture capital firm, launched a $307 million fund for Israeli med-tech investments. The VC investor has over $15 billion in assets under mangement and is known for the successful exit of its portfolio company eCam Biotherapeutics, which was acquired by Merk for over $600 million.
The Conexx delegation also had some very sucessful meetings, including one with Teva Israel.